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Antibiotics are used in livestock and poultry production to treat and prevent disease as well
as to promote animal growth. Carbadox is an in-feed antibiotic that is widely used in swine
production to prevent dysentery and to improve feed efficiency. The goal of this study was
to characterize the effects of carbadox and its withdrawal on the swine gut microbiota. Six
pigs (initially 3-weeks old) received feed containing carbadox and six received unamended
feed. After 3-weeks of continuous carbadox administration, all pigs were switched to
a maintenance diet without carbadox. DNA was extracted from feces (n = 142) taken
before, during, and following (6-week withdrawal) carbadox treatment. Phylotype analysis
using 16S rRNA sequences showed the gradual development of the non-medicated swine
gut microbiota over the 8-week study, and that the carbadox-treated pigs had significant
differences in bacterial membership relative to non-medicated pigs. Enumeration of fecal
Escherichia coli showed that a diet change concurrent with carbadox withdrawal was
associated with an increase in the E. coli in the non-medicated pigs, suggesting that
carbadox pre-treatment prevented an increase of E. coli populations. In-feed carbadox
caused striking effects within 4 days of administration, with significant alterations in
both community structure and bacterial membership, notably a large relative increase in
Prevotella populations in medicated pigs. Digital PCR was used to show that the absolute
abundance of Prevotella was unchanged between the medicated and non-medicated pigs
despite the relative increase shown in the phylotype analysis. Carbadox therefore caused a
decrease in the abundance of other gut bacteria but did not affect the absolute abundance
of Prevotella. The pending regulation on antibiotics used in animal production underscores
the importance of understanding how they modulate the microbiota and impact animal
health, which will inform the search for antibiotic alternatives.
Keywords: carbadox, antibiotics, microbiome, phylotype, 16S rRNA, digital PCR
INTRODUCTION
Antibiotics are used in animal agriculture for both therapeu-
tic and non-therapeutic applications (Animal Health Institute,
2012). Appropriately high doses of antibiotics are adminis-
tered to treat or prevent disease (therapeutic use), and rela-
tively low doses are typically used to improve feed efficiency
(non-therapeutic use). These differing doses of antibiotics are
important because they are at the core of regulatory efforts,
with many countries banning or regulating non-therapeutic
veterinary antibiotics that have human medical importance
(European Union, 2003; FDA, 2012). This is because low-
dose antibiotics can result in bodily concentrations of antibi-
otics that are subinhibitory to bacteria. Indeed, it is likely
that both therapeutic and non-therapeutic doses of antibiotics
can lead to subinhibitory antibiotic concentrations for some
host-associated bacteria. Subinhibitory antibiotic concentrations
are undesired because they can have adverse effects, in par-
ticular enhancing the selection for antibiotic resistance genes
and their horizontal transfer (Barbosa and Levy, 2000; Smith
et al., 2002; Barlow, 2009; Brewer et al., 2013), thus promoting
the antibiotic resistance problem in animal and human
pathogens.
Carbadox is a quinoxaline-di-N-oxide antibiotic compound
that is fed to almost a third of nursery-age pigs in the US to con-
trol enteric diseases and improve feed efficiency (USDA, 2007).
Medicated early weaning, including carbadox, is credited with
nearly eradicating the enteric pathogen Brachyspira hyodysente-
riae in domestic swine [cause of swine dysentery (Stanton et al.,
1999)]. Carbadox inhibits bacteria by intercalating DNA and
causing mutations, and this mutagenic property has led to its ban
in many countries (Beutin et al., 1981; Chen et al., 2009). The
current US regulation includes a 42-day withdrawal period prior
to slaughter to prevent carbadox residues in the carcass (Joint
FAO/WHO Expert Committee on Food Additives, 2003). It is
unclear if it will be further regulated in the US because carbadox
is not an antibiotic of human clinical importance (FDA, 2003).
We are interested in carbadox because of its importance to the
US swine industry and its unknown effects on swine gut bac-
teria. One specific collateral effect of carbadox is the induction
of prophages or prophage-like gene transfer agents, as has been
shown in vitro in Shiga toxin-producing Escherichia coli (Kohler
et al., 2000), Salmonella enterica serovar Typhimurium (Bearson
et al., 2014), and B. hyodysenteriae (Stanton et al., 2008). In addi-
tion to these results, research in our lab on total swine fecal
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phages suggested that prophages were induced in pigs that were
fed either carbadox or ASP250 (penicillin, chlortetracycline, sul-
famethazine) (Allen et al., 2011). Further identification of the
effects of carbadox on the swine gut microbiome could lead to
a greater understanding of its mechanism of growth promotion.
Here we analyzed the bacterial component of the swine fecal
microbiota in samples taken prior to and during carbadox treat-
ment, as well as periodically during the 6-week withdrawal
period. We found that carbadox altered bacterial membership
and community structure relative to non-medicated pigs, includ-
ing a reduction in total bacteria. This study is an important step
toward defining the effects of carbadox on the swine gut micro-
biome, which in turn will lead to informed alternatives to this
antibiotic.
MATERIALS AND METHODS
SWINE
Piglets were acquired and managed in accordance with the
National Animal Disease Center Animal Care and Use Committee
guidelines, as previously described (Allen et al., 2011). At 3 weeks
of age, 12 piglets from 2 litters were divided into two rooms of
six pigs each, with equal representation of littermates and gen-
der. All pigs were fed a standard starter diet (TechStart® 17-25,
Kent Feeds, Muscatine, IA) ad libitum for 3 weeks, after which six
control pigs continued to receive non-medicated feed while the
other group received feed containing carbadox (50 g/ton). After
21 days of continuous feed with or without carbadox, all pigs (60
days old) were switched to a non-medicated maintenance diet
(Pork Finisher diet, Kent Feeds). The age of pigs receiving car-
badox and transitioning to maintenance diet are consistent with
standard industry practices.
Feces were collected from each pig at multiple times before,
during, and after antibiotic withdrawal (Figure 1), and DNAs
were extracted with the PowerBiome DNA Isolation Kit using the
manufacturer’s protocol (Mo Bio Laboratories, Solana Beach, CA,
USA).
16S rRNA GENE SEQUENCING
Amplification of the V1-V3 region of bacterial 16S rRNA genes
from individual samples was carried out as previously described
(Allen et al., 2011). Primers 8F (5′-AGAGTTTGATCCTGGC
TCAG) (Weisburg et al., 1991) and 518R (5′-ATTACCGCGGCT
GCTGG) (Muyzer et al., 1993) were designed with an eight-
nucleotide unique sequence barcodes (Hamady et al., 2008; Allen
et al., 2011). PCRs were performed for 22 cycles, and the prod-
ucts were separated by gel electrophoresis and purified using
the MinElute kit (Qiagen Inc., Valencia, CA). Amplicons were
sequenced on a 454 Genome Sequencer (GS) FLX using the man-
ufacturer’s protocol for Titanium chemistry (Roche Diagnostics,
Branford, CT).
SEQUENCE ANALYSIS
Sequence data that passed Roche’s quality thresholds were pro-
cessed by AmpliconNoise (Quince et al., 2011), mothur (Schloss
et al., 2009, 2011), and Uchime (Edgar et al., 2011) to denoise
sequencing data, remove barcodes, and reduce sequence artifacts
produced during PCR. The Schloss analysis pipeline SOP was fol-
lowed (Schloss et al., 2011). Briefly, mothur’s implementation of
the AmpliconNoise program reduced sequencing and PCR arti-
facts, then sequences were aligned to the Silva bacterial database
(Quast et al., 2013). Screen.seqs, filter.seqs, and pre.cluster com-
mands were performed in mothur to improve the quality of the
dataset, and Uchime was used to remove chimeras (using the
sequences of each sample as their own reference). OTU-based
phylogenetic analysis (97% similarity cutoff) and hypothesis test-
ing were performed with normalized data in mothur (Schloss
et al., 2009). Data were normalized by subsampling each sam-
ple to 3454 reads and unless otherwise stated, and samples were
analyzed by time and treatment (Figure 1). To visualize changes
in community structure, the Bray-Curtis dissimilarity statistic
(OTU data) and Pearson’s correlations (vectors of environmental
variables) were calculated and plotted by nonmetric multidi-
mensional scaling (NMDS) in PAST (Hammer et al., 2001).
FIGURE 1 | Timeline of carbadox feed-trial. Sample days are noted above the thick line, and dates are noted below. Dashed region not to scale. Timepoints
that were grouped for some statistical analyses are labeled along the top. CARB, carbadox; WD, withdrawal.
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Community metrics such as diversity (Shannon index, inverse
Simpson index), evenness (Heips index), and richness [best para-
metric model in CatchAll (Bunge, 2011; Bunge et al., 2012)] were
calculated in mothur based on the OTU data. Multiple t-tests
were performed on community metrics in GraphPad Prism v.
6.02 (La Jolla, CA). Statistical significance was determined using
the Holm-Sidak correction for multiple comparisons when com-
paring medicated vs. non-medicated at a timepoint, or using the
Kruskal-Wallis test with Dunn’s multiple comparison correction
when comparing the all days of the carbadox group to pre-
treatment (alpha= 5%). The resilience index was calculated from
Shannon, Heips evenness, and inverse Simpson diversity indices
using the formula described by Shade et al. (2012) based on the
diversity index of the microbiota of the carbadox-treated animals
at pre-treatment, at the most significantly changed time (day 7),
and at the first time that was not significant from pre-treatment
(day 14). Samples were analyzed by treatment per timepoint, or
by treatment per range of time (pre-treatment, early carbadox
exposure [days 1–4], late carbadox exposure [days 7–21], early
withdrawal [days 2 and 4], and late withdrawal [days 21 and 42];
Figure 1). For most statistics, samples were compared between
pigs in the medicated and non-medicated groups at each time.
Taxonomic assignments of the 16S rRNA gene sequences were
made using the Ribosomal Database project (RDP) web tools,
with training set version 9.0 (Cole et al., 2009). The Metastats
statistical software was used in mothur for making comparisons
between samples and identifying trends (White et al., 2009).
Analysis of similarities (ANOSIM) was also performed in mothur
to test whether difference between groups were significant.
Linear discriminant analysis effect size (LEfSe) was per-
formed using the LEfSe web tool on taxonomic assignments from
RDP’s sequence classifier (Cole et al., 2009; Segata et al., 2011).
The LEfSe program was used to identify indicator organisms
most likely to explain the differences between treatment groups
with a logarithmic cutoff value of linear discriminant analysis
(LDA)> 4.0.
QUANTIFICATION OF PREVOTELLA (BY digPCR AND qPCR)
Digital PCR (digPCR) counts the number of target molecules
in each DNA sample, enabling reliable estimates of the abso-
lute number of target molecules in the original sample (feces),
without the need for an internal standard. Digital PCR was
performed to estimate the number of copies of Prevotella 16S
rRNA genes in fecal DNA from carbadox-fed and non-medicated
animals at day 4 of carbadox treatment (early exposure). The
Quantstudio 3D digPCR system (Life Technologies) was used
according to the manufacturer’s recommendations and each sam-
ple was run in triplicate. Prevotella-specific digPCR primers were
adapted from Mieszkin et al. (2009): Bac32 Fm, 5′AACGCTAG
CTACAGGCTTAAC; Bac108R, 5′ CGGGCTATTCCTGACTATG
GG; Bac82Probe, 5′ 6-FAM-ACGGGTGAG/ZEN/TAACGCGT
ATCCAAC-IBFQ (fluorophore and quenchers in bold). All reac-
tions were performed using QuantStudio 3D Digital PCR Master
Mix (Life Technologies, Carlsbad, California) following manu-
facturer’s recommended cycling conditions. Each 15μL reaction
consisted of 1.0μMof each primer, 0.2μMprobe, 1.0 ng or 0.1 ng
DNA. Prevotella cells per gram of feces were calculated using the
DNA quantity extracted from 0.5 grams of feces, and assuming a
Prevotella spp. average of two 16S rRNA gene copies per cell [aver-
age of 58 Prevotella genomes available on the IntegratedMicrobial
Genomes (IMG) website (Markowitz et al., 2012)].
Quantitative PCR (qPCR) was performed on the same samples
as digPCR to evaluate the relative amount of Prevotella to total
16S rRNA gene copies (all bacteria). Prevotella-specific primers
were used (F, 5′CGGGTTGTAAACTGCTTTTATGAAG; and
R, 5′CGCTCCCTTTAAACCCAATAAA) as previously described
(Okabe et al., 2007). Universal bacterial primers targeting the
16S rRNA gene (341F, 5′ CCTACGGGRSGCAGCAG; and 529R,
5′ ACCGCGGCKGCTGGC) (Baker et al., 2003) were used to
amplify all bacterial 16S rRNA genes. All reactions were done
using iTaq Universal SYBR Green Supermix following manufac-
turer’s recommended conditions (Bio-Rad, Hercules, California).
Each 20μL reaction consisted of 0.01 ng fecal DNA and the
Prevotella or universal primers at 0.2μM or 0.5μM, respectively.
Relative quantification was calculated using the Pfaffl method
(Pfaffl, 2001) and t-tests were performed in PAST (Hammer et al.,
2001).
E. COLI VIABLE CELL POPULATIONS
One gram of fresh feces was suspended in 10ml LB broth.
Samples were vortexed vigorously to make a slurry for 10-fold
serial dilutions in phosphate buffered saline. Duplicate dilutions
were plated on MacConkey agar medium (March and Ratnam,
1986) and incubated at 37◦C. Lactose positive colonies (fecal col-
iforms, predominantly E. coli) were enumerated on the countable
dilution the following day.
DATA PRESENTATION
A P-value less than 0.05 with a q-value (false discovery rate)
less than 0.05 was considered significant, and R between 0
and 0.3 was considered a slight correlation while R greater
than 0.3 was considered a correlation. Data are deposited
in NCBI’s Short Read Archive (SRA) under accession num-
bers SAMN02645017-SAMN02645066 and are associated with
BioProject PRJNA237795.
RESULTS
CARBADOX ALTERS BACTERIAL MEMBERSHIP EARLY IN THE
TREATMENT
We first examined differences in bacterial membership at the
phylum and genus taxonomic levels during the first week of
carbadox treatment. The results showed that the Firmicutes,
Proteobacteria, Elusimicrobia, Planctomycetes, and Lentisphaerae
phyla were of lower relative abundance, while the Bacteroidetes
phylum was of higher abundance in the medicated animals
(q < 0.03) (Figure 2). Interestingly, Bacteroidetes populations
increased in the medicated animals proportionately to the
decrease in Firmicutes populations (∼17% change). This early
carbadox-mediated transition to a Bacteroidetes-dominantmicro-
biota was also seen when comparing early medicated animals to
pre-treatment (∼25%). Genus-level taxonomic assignments were
also analyzed, revealing significant differences between the med-
icated and non-medicated animal microbiotas during the early
carbadox time points. Many genera showed a relative decrease
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FIGURE 2 | Bacterial phyla representation in the microbiota, based on
taxonomic inference of bacteria (16S rRNA sequences). Data are pooled
by treatment and period of time. Carb, carbadox; wd, withdrawal; non,
non-medicated.
with antibiotic treatment (Figure S1), most of which belonged
to the Firmicutes phylum (q < 0.05). The relative increase in
Prevotella spp. was reflected in the increase in Bacteroidetes in the
carbadox-treated animals (q < 0.05).
The LEfSe analysis was used to resolve bacterial taxa associ-
ated with antibiotic treatment, which could define biomarkers
for carbadox effects. This analysis explains why biological sam-
ples differ using tests of consistency and effect size estimation
(Segata et al., 2011), with the results suggesting members of the
community that benefit from or contribute to the community-
wide effects described above. The results showed four genera to be
enriched in early samples from carbadox-fed animals: Prevotella,
Roseburia, Faecalibacterium, and Asteroleplasma (Figure 3 and
Figure S2). Lactobacillus was enriched in samples from the early
non-medicated animals (Figure 3 and Figure S2). This indicates
that a few key members of the community could be the drivers of
community dynamics.
CARBADOX CAUSES RAPID CHANGES IN BACTERIAL COMMUNITY
STRUCTURE
Comparisons of community structures apply broad measures
of similarities among bacterial communities in their entirety,
allowing inferences to be made about populations as a whole.
The effects of dietary changes on bacterial community struc-
ture were first analyzed via OTUs binned at the 97% similarity
level. Estimates of the total number of OTUs (bacterial rich-
ness) during the early treatment period were significantly lower
for the communities in medicated animals (661 ± 55 vs. 962 ±
96, respectively; Figure 4). Additional measures of alpha diver-
sity (Shannon diversity, Heips evenness, and inverse Simpson
indices) of samples from medicated animals compared to non-
medicated animals were significantly different at 2, 3, and 4 days
after continuous carbadox, but not different in either late car-
badox or at any time during the withdrawal period (Figure S3).
Analysis of the community structure yielded further support,
showing significant differences at days 3 and 4 of early carba-
dox treatment ([R = 0.32, p = 0.015] and [R = 0.54, p = 0.003],
respectively), but not before starting antibiotic treatment (p =
0.82; Figure 5). Communities from medicated animals at the
remaining time points did not clearly separate from those of the
non-medicated animals. The alpha diversity indices of the micro-
biota from the carbadox-treated animals at each sample time were
compared to their pre-treatment values to determine when the
microbiota recovered. Significant differences were revealed from
the pre-treatment diversity at days 2, 3, 4, and 7 but at no other
times, including the withdrawal period (p < 0.01). The swine
gut microbiota showed similar resilience in response to carbadox
disturbance regardless of the diversity index used to calculate it
(0.16, 0.17, 0.19 from the Heips evenness, inverse Simpson, and
Shannon diversity indices, respectively). Together these data show
that carbadox caused an initial decrease in both bacterial rich-
ness and evenness, and that the swine gut bacterial community
structure recovered after 1 week of carbadox initiation despite the
continued presence of carbadox.
COMPARISON OF ABSOLUTE AND RELATIVE DIFFERENCES IN
MICROBIOTA MEMBERSHIP
Because of the altered microbial diversity and reduction of rich-
ness early in the antibiotic treatment, digital PCR was used to
evaluate whether statistically significant changes in the bacterial
community of medicated animals was due to absolute changes in
bacterial membership or due to reductions of carbadox-sensitive
organisms. The relative abundance of Prevotella was most signif-
icantly impacted by carbadox and so was chosen for analysis by
digPCR to determine if this was an absolute or relative change in
the Prevotella population. Analysis of early carbadox samples (day
4) showed no significant differences in Prevotella counts (LOG10)
per gram of feces between medicated (10.0, SE = 0.11) and non-
medicated animals (9.8, SE = 0.26). This suggests that observed
differences in Prevotella sequence data are due to decreases
of other bacterial species rather than to increases in absolute
numbers of Prevotella. To verify the results of the phylotype
analysis and to compare with the digPCR results, qPCR was
performed on the same day 4 samples. Quantitative PCR of
Prevotella abundances, relative to total 16S rRNA genes, con-
firmed a 1.8-fold increase in the relative abundance of Prevotella
in the carbadox-fed animals (p < 0.05). These data demonstrate
the value of using digPCR to resolve the absolute abundance of
taxa that show relative changes in high-throughput phylotype
analyses.
CARBADOX ABROGATES E. COLI POPULATION SHIFTS DURING A
DIETARY CHANGE
Culturing bacteria directly from feces also yields absolute counts,
but selecting individual groups requires a priori knowledge and
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FIGURE 3 | Taxonomic tree showing biomarkers that were significantly
enriched with either antibiotic exposure or lack of exposure over time.
The LEfSe-generated tree shows bacterial nodes (diameter is relative to
abundance in community) with a taxonomic hierarchy. Samples were grouped
together as either carbadox-treated (Carb) or non-medicated (Non-med) over
the period of the study as pre-treatment, early exposure, late exposure, early
withdrawal, late withdrawal. No biomarkers were identified for the late
carbadox samples. The cutoff value of linear discriminant analysis (LDA) > 4.0.
available selective media. Because carbadox is often used to pre-
vent enteric diseases in young swine, we cultured E. coli from
fecal samples at different experimental time points to monitor
this species for potential enteric pathogens. No significant dif-
ferences in E. coli colony forming units (CFUs) were observed
during the carbadox-treatment portion of the study or late in the
withdrawal period (Figure S4). Interestingly, E. coli CFUs were
significantly different between the medicated and non-medicated
groups on day 2 after the withdrawal of carbadox, with the dif-
ference being driven by increased E. coli CFUs in samples from
non-medicated animals at that time (Figure S4). The diet for all
animals was switched (consistent with industry practice) con-
comitant with the withdrawal of carbadox (seeMethods), and this
result suggests that the change in diet caused a brief increase in
E. coli populations that was prevented in the pigs previously fed
carbadox.
CARBADOX MODIFIES THE DEVELOPMENT OF THE SWINE GUT
MICROBIOTA
This study involved a time series that encompassed 21 days
of antibiotic treatment and 42 days following its withdrawal,
enabling the examination of the development of the swine gut
microbiota. Members of the Firmicutes phylum were relatively
more abundant at the beginning of the study (54% of total com-
munity) than at the end of the withdrawal period (34%) (q <
0.01; Figure 2). An increase in the relative abundance of other
phyla [Proteobacteria, Spirochaetes, Planctomycetes, Fibrobacteres,
Synergistetes (q < 0.01)] was observed over the 9-week study.
Much of this maturation happened late in the experiment regard-
less of antibiotic treatment. However, carbadox treatment did
exert some significant changes on the microbiota even after its
withdrawal. Analysis of community structure revealed significant
differences between the medicated and non-medicated groups
late in the withdrawal period (21 days [R = 0.49, p = 0.001] and
42 days [R = 0.54, p = 0.001]), but not in the early withdrawal
period (days 1, 2, 3, or 4) (Figure 5). This suggests significant
changes in bacterial membership over time because there were
no significant differences in comparisons of community met-
rics, such as richness and diversity, during the withdrawal period
(Figure 4 and Figure S3). The LEfSe analysis suggested bacterial
members were relatively increased with these late-withdrawal dif-
ferences, including Succinivibrio, Hallella, and Treponema in the
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late-withdrawal medicated animals and Spirochaetaceae in the late
non-medicated animals (Figure 4). Taken together, these results
show that the swine gut bacterial community changes over time,
and that carbadox influences thesemicrobiotas even several weeks
after its removal.
FIGURE 4 | Operational Taxonomic Unit (OTU) estimates, averaged by
treatment and time. Bars indicate the standard error around the mean.
Multiple comparisons star indicates significant difference at timepoint.
DISCUSSION
Here we define short- and long-term effects of in-feed car-
badox and its withdrawal on the swine intestinal microbiota.
Carbadox is one of the most common antibiotics used in the
US swine industry, with indications for both disease prevention
and feed-efficiency improvement. We are interested in defining
the effects of carbadox to inform both its mechanism-of-action
and non-antibiotic alternatives (with similar effects on produc-
tion performance). Carbadox was administered continuously for
3 weeks, constituting an ecological press rather than pulse dis-
turbance to the microbiota (Shade et al., 2012). The results show
that carbadox immediately and significantly altered the bacte-
rial community, but it did not show the same effects from 1 to
3 weeks of continual administration. This demonstrates that the
swine gut microbiota was initially disturbed by carbadox, but the
microbial community structure recovered despite the continued
presence of carbadox. Interestingly, the discontinuation of carba-
dox resulted in enduring effects at the species level but not on
community metrics such as diversity, suggesting that carbadox
altered the membership but not the structure of the commu-
nity. Similar dynamics were observed in a study of a human
undergoing press β-lactam therapy, which showed an immediate
reduction in Firmicutes populations after 6 days, a reduction
in overall species richness, and subsequent reestablishment of
Firmicutes populations after 2 weeks (Perez-Cobas et al., 2013).
Furthermore, analysis of physiochemical and microbial variables
in a batch reactor has shown that microbial communities can
FIGURE 5 | Non-metric multidimensional scaling analysis of
OTU-based bacterial 16S rRNA gene sequence abundances in
individual pig samples. Environmental variables are plotted as
vectors. The length of each vector is arbitrarily scaled, so only
their directions and relative lengths should be considered. Stress
proportion = 0.1656.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy June 2014 | Volume 5 | Article 276 | 6
Looft et al. Short- and long-term antibiotic effects
enter alternative stable states that have consequences on ecosys-
tem processes (Burgmann et al., 2011). Further work is needed
to determine how the carbadox-altered microbiota interacts with
the host and how this relates to feed efficiency.
The most dramatic bacterial change was the relative increase
in the Prevotella population during the first 4 days of carba-
dox exposure. However, based on the digPCR results, this was
not due to an absolute increase in the Prevotella population,
which was unchanged compared with samples from non-treated
pigs, but rather to a reduction in other members of the micro-
biota. Prevotella is a well-studied swine commensal bacterium
and has been identified as one of the most abundant genera
in the pig intestine (Leser et al., 2002; Lamendella et al., 2011;
Looft et al., 2012). The relative number of intestinal Prevotella
has been shown to decrease after amoxicillin exposure (Mozes
et al., 2013), suggesting that the antimicrobial effect on this genus
is specific to the antibiotic being administered. Prevotella spp.
metabolize recalcitrant food, such as hemicelluloses and pectin
in the swine intestinal tract, which is important to animal health
because fermentation end products, from these substrates, sup-
ply the host with a large portion of its energy supply. Prevotella
was identified with Roseburia and Faecalibacterium as biomarkers
that increase in relative abundance soon after carbadox admin-
istration. These bacteria are metabolically complementary since
Prevotella produces acetate, and Roseburia and Faecalibacterium
consume acetate to produce butyrate (Duncan et al., 2004a,b).
Butyrate is a short chain fatty acid (SCFA) that has been shown
to benefit host health (Flint et al., 2012; Furusawa et al., 2013).
Additionally, links between bacterial fermentation products and
host energy regulation suggest bacterial roles for improved feed
efficiency. A recent study of fructo-oligosaccharides and other
soluble fibers showed an intestinal microbiota shift in mice
(increased Bacteroidetes populations and decreased Firmicutes)
that resulted in increased SCFA production, specifically acetate,
propionate, and butyrate (De Vadder et al., 2014). This led
to increased concentrations of propionate in the blood, which
induced intestinal gluconeogenesis to benefit glucose and energy
homeostasis (De Vadder et al., 2014). Although the relative
Prevotella increase in response to carbadox was relatively short-
lived, and not an absolute change, studies of food-producing
animals suggest that small health advantages at key production
stages (e.g., weaning, transport, etc.) can convey significant per-
formance improvements over time and at slaughter (Alexopoulos
et al., 2004).
The health benefits of microbial SCFA production has been
well documented, and certain diets and antibiotic alterna-
tives have been shown to be particularly good modulators of
SCFAs. Interestingly, studies on the host health- and microbiota-
modulating effects of some prebiotics, such as dietary fiber, have
shown microbiota shifts similar to what was shown in the present
study with carbadox. The prebiotics arabinoxylan and inulin
similarly caused a relative increase in Prevotella, Roseburia, and
Faecalibacterium populations, thereby increasing propionate and
butyrate production (Ramirez-Farias et al., 2009; Scott et al.,
2014). Prevotella spp. also had relative increases after soluble
fiber and non-starch polysaccharides were added to pig feed,
and this diet was also associated with increased abundance of
butyryl-coenzyme A (CoA) CoA transferase gene copies in feces
(Metzler-Zebeli et al., 2010). It is as yet unclear if these micro-
biota shifts are related to the improved feed efficiency observed
with agricultural antibiotics such as carbadox, but further studies
are warranted.
One unexpected discovery was that carbadox abrogates a
potential bloom in E. coli populations as a result of a diet change.
Previous results from our lab and others have suggested that
increased E. coli populations are a collateral effect of some ecosys-
tem disturbances, including antibiotics (Janczyk et al., 2007; Looft
and Allen, 2012). An abrupt change in diet has been shown to
increase E. coli O157:H7 shedding in sheep (Kudva et al., 1997)
and in pigs, diet change and weaning is associated with increase
susceptibility to enterotoxigenic E. coli infection, a leading cause
of post-weaning diarrhea (Wu et al., 2007). In the present study,
we found that the initial carbadox disturbance caused no such
E. coli increase. However, due to the pigs advancing age over the
course of our extended experiment, the diet was changed from
a standard nursery diet to a grower/maintenance diet (consis-
tent with industry practice) at the same time that carbadox was
withdrawn. This dietary change caused an increase in E. coli pop-
ulations in the non-medicated animals, but not in the pigs that
had previously been fed carbadox, demonstrating a protective
effect of prior carbadox administration.
In contrast to the potential modulation of SCFA production
described above, other commonly accepted mechanisms of how
in-feed antibiotics improve feed efficiency are related to bacterial
disease suppression, the reduction of the host’s microbial load,
or both (Dibner and Richards, 2005; Mathew et al., 2007). Our
study showed a significant reduction of bacterial species richness
after 4 days of continuous carbadox administration, confirming
that the bacterial load is reduced albeit temporarily. Reduced
bacterial richness has also been observed with the use of other
in-feed antibiotics such as ASP250 (chlortetracycline, sulfamet-
hazine, and penicillin) in swine (Allen et al., 2011). Regarding
the potential mechanism of disease suppression, an intriguing
result from our study is that the family Spirochaetaceae was
lower in the carbadox-treated animals than the matched non-
medicated animals 42 days after the withdrawal of carbadox. The
Spirochaetaceae family includes Brachyspira hyodysenteriae, which
is the causative agent of swine dysentery and one of the primary
reasons carbadox is used in pig production in the US (Stanton
et al., 1999). As efficacious alternatives to in-feed antibiotics con-
tinue to be explored, these data are a reminder of the need to
diversify the antibiotic alternative armament with specific tools of
targeting pathogens, such as vaccines, in addition to feed additives
that are general modulators of bacterial community structure
(Allen et al., 2013).
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